-
1
Immune checkpoint inhibitors can induce severe immune-related adverse events, including the life-threatening 3M syndrome.
-
2
3M syndrome is characterized by the combination of immune myocarditis, myositis, and myasthenia gravis, leading to high mortality.
-
3
Early symptoms of 3M syndrome, such as ptosis and facial weakness, are often subtle and can be misattributed to other conditions.
-
4
A 65-year-old female patient developed 3M syndrome after anti-PD-1 therapy for cervical cancer, resulting in acute heart failure.
-
5
Proactive monitoring and immediate immunosuppressive treatment are essential for managing the risks associated with immunotherapy.
